Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the start of another day comes our breakdown of the biggest pre-market stock movers and this time it’s for Thursday! Source: ventdusud / Shutterstock.com Earnings reports, heavy volume, and more have sto...
Check-Cap Ltd. (NASDAQ:CHEK) has added ~7% in the pre-market Wednesday after the clinical-stage medical diagnostics company announced the initiation of a U.S. pivotal trial for C-Scan, an investigational screening test to detect colorectal cancer. The two-part open-label trial start...
Check-Cap Announces Initiation of the U.S. Pivotal Trial PR Newswire ISFIYA, Israel , May 11, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the...
Check-Cap press release (NASDAQ:CHEK): Q4 GAAP EPS of -$0.21 misses by $0.16. Cash and cash equivalents, restricted cash and short-term bank deposits as of December 31, 2021 were $51.9M. For further details see: Check-Cap GAAP EPS of -$0.21 misses by $0.16
Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results PR Newswire Company anticipates initiation of the first part of its U.S. pivotal study in April 2022 ISFIYA, Israel , April 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "...
Check-Cap Ltd. (NASDAQ:CHEK) traded at a new 52-week high today of $19.77. Approximately 301.1 million shares have changed hands today, as compared to an average 30-day volume of 1.7 million shares. Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development ...
Check Cap (NASDAQ:CHEK) has slumped ~34% pre-market after the medical diagnostics firm announced a $10M equity offering. The offering comprises 20M of the company's ordinary shares and accompanying warrants to purchase up to an aggregate of 15M of the its ordinary shares. Each ordin...
Check-Cap Ltd. Announces $10 Million Registered Direct Offering PR Newswire ISFIYA, Israel , March 1, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancin...
Check-Cap (NASDAQ:CHEK) plans to start the U.S. pivotal study for its C-Scan cancer screening test after the FDA approved its amended Investigational Device Exemption (IDE) application, the company announced on Monday. Designed to identify the polyps before they become colorectal cancer, C-Sc...
Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan Company anticipates initiation of first part of pivotal study in the March-April 2022 timeframe PR Newswire ISFIYA, Israel , Feb. 7, 2022 /PRNewswire/ -- Check-Cap Ltd. ...
News, Short Squeeze, Breakout and More Instantly...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
Commercial Metals Company (CMC) is expected to report $1 for Q3 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 GMS Inc. (GMS) is expected to report $2.04 for Q4 2024 China Jo-Jo Drugstores Inc. (CJJD) is expected to report for Q4 2024 Eiger BioPharmaceuticals Inc. (EIGR...
Usinas Siderurgicas De Minas Gerais S.A. ADR (Representing Pref Share Cl A) (USNZY) is expected to report $0 for Q2 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Senstar Technologie...